Drug therapy for pulmonary nontuberculous mycobacterial disease

Ho Namkoong, Naoki Hasegawa

Research output: Contribution to journalArticle

Abstract

A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.

Original languageEnglish
Pages (from-to)1084-1094
Number of pages11
JournalJapanese Journal of Chest Diseases
Volume74
Issue number10
Publication statusPublished - 2015 Oct 1

Fingerprint

Drug Therapy
Lung
Mycobacterium avium Complex
Ethambutol
Clarithromycin
Rifampin
Japan
Guidelines
Physicians
Pharmaceutical Preparations

Keywords

  • Drug therapy
  • MAC/nontuberculous mycobacteria
  • Mycobacterium avium complex

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Drug therapy for pulmonary nontuberculous mycobacterial disease. / Namkoong, Ho; Hasegawa, Naoki.

In: Japanese Journal of Chest Diseases, Vol. 74, No. 10, 01.10.2015, p. 1084-1094.

Research output: Contribution to journalArticle

@article{11b055fc46844a97a5395ac1bdbf3786,
title = "Drug therapy for pulmonary nontuberculous mycobacterial disease",
abstract = "A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.",
keywords = "Drug therapy, MAC/nontuberculous mycobacteria, Mycobacterium avium complex",
author = "Ho Namkoong and Naoki Hasegawa",
year = "2015",
month = "10",
day = "1",
language = "English",
volume = "74",
pages = "1084--1094",
journal = "Japanese Journal of Chest Diseases",
issn = "0385-3667",
publisher = "Kokuseido Publishing Co. Ltd",
number = "10",

}

TY - JOUR

T1 - Drug therapy for pulmonary nontuberculous mycobacterial disease

AU - Namkoong, Ho

AU - Hasegawa, Naoki

PY - 2015/10/1

Y1 - 2015/10/1

N2 - A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.

AB - A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.

KW - Drug therapy

KW - MAC/nontuberculous mycobacteria

KW - Mycobacterium avium complex

UR - http://www.scopus.com/inward/record.url?scp=84946029280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946029280&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84946029280

VL - 74

SP - 1084

EP - 1094

JO - Japanese Journal of Chest Diseases

JF - Japanese Journal of Chest Diseases

SN - 0385-3667

IS - 10

ER -